Cargando…
Prevalence and determinants of iron deficiency in cardiac amyloidosis
AIMS: Iron deficiency (ID) is common in patient with chronic heart failure (HF) and has been widely studied. In contrast, data concerning ID in cardiac amyloidosis (CA) are limited. Amyloidosis is a severe and fatal systemic disease, characterized by an accumulation of amyloid fibrils in various tis...
Autores principales: | Jobbé‐Duval, Antoine, Bézard, Mélanie, Moutereau, Stéphane, Kharoubi, Mounira, Oghina, Silvia, Zaroui, Amira, Galat, Arnault, Chalard, Coraline, Hugon‐Vallet, Elisabeth, Lemonnier, Francois, Eyharts, Damien, Poulot, Elsa, Fanen, Pascale, Funalot, Benoit, Molinier‐Frenkel, Valérie, Audard, Vincent, Hittinger, Luc, Delbarre, Marc Antoine, Teiger, Emmanuel, Damy, Thibaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934992/ https://www.ncbi.nlm.nih.gov/pubmed/35128833 http://dx.doi.org/10.1002/ehf2.13818 |
Ejemplares similares
-
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment
por: Oghina, Silvia, et al.
Publicado: (2021) -
History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
por: Kharoubi, Mounira, et al.
Publicado: (2021) -
Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2020) -
Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement
por: Bézard, Mélanie, et al.
Publicado: (2021) -
Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2023)